Oragenics Inc. (OGEN) financial statements (2022 and earlier)

Company profile

Business Address 4902 EISENHOWER BLVD
TAMPA, FL 33634
State of Incorp. FL
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments27,26617,64018,26820,2086,1664,0815,083
Cash and cash equivalents27,26617,64018,26820,2086,1664,0815,083
Receivables7     21
Inventory, net of allowances, customer advances and progress billings      322
Inventory      322
Other undisclosed current assets4353435701,7251,027141212
Total current assets:27,70717,98318,83821,9337,1934,2225,638
Noncurrent Assets
Operating lease, right-of-use asset478655823
Property, plant and equipment4643921162287141
Total noncurrent assets:5246989151162287141
TOTAL ASSETS:28,23118,68119,75322,0507,2154,3095,778
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:9489371,5411,0438181,277970
Accounts payable8553301,207829618461384
Accrued liabilities2184554749169159
Employee-related liabilities584061431231079388
Other undisclosed accounts payable and accrued liabilities141161364544553340
Debt303228309124806663
Deferred revenue and credits  14
Other undisclosed current liabilities194177     
Total current liabilities:1,4451,3421,8501,1688991,3431,047
Noncurrent Liabilities
Long-term debt and lease obligation300494671    
Operating lease, liability300494671
Other undisclosed noncurrent liabilities(300)(494)     
Total noncurrent liabilities:300494671    
Total liabilities:1,7451,8362,5211,1688991,3431,047
Stockholders' equity
Stockholders' equity attributable to parent26,48616,84517,23220,8826,3162,9664,731
Preferred stock2,6577,1756,5136,1006,310  
Common stock11692462954940
Common stock, share subscribed but unissued, subscriptions receivable     (31) 
Additional paid in capital194,987164,023138,025126,126101,40397,61692,347
Accumulated deficit(171,274)(154,445)(127,353)(111,374)(101,401)(94,669)(87,656)
Total stockholders' equity:26,48616,84517,23220,8826,3162,9664,731
TOTAL LIABILITIES AND EQUITY:28,23118,68119,75322,0507,2154,3095,778

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues87     1,176
Revenue, net  1,176
Cost of revenue
(Cost of Goods and Services Sold)
      (482)
Gross profit:87     694
Operating expenses(15,858)(26,641)(15,878)(9,994)(6,718)(8,543)(12,346)
Operating loss:(15,771)(26,641)(15,878)(9,994)(6,718)(8,543)(11,652)
Nonoperating income (expense)5921131280(13)45(59)
Investment income, nonoperating7689320871994021
Other nonoperating income12007141
Interest and debt expense(16)(11)(7)(6)(216)(4)(77)
Loss from continuing operations before equity method investments, income taxes:(15,727)(26,441)(15,573)(9,920)(6,948)(8,501)(11,788)
Other undisclosed income from continuing operations before income taxes161176216477
Loss from continuing operations before income taxes:(15,712)(26,431)(15,566)(9,914)(6,732)(8,497)(11,711)
Income tax expense (benefit) (6,483)(3,874)(2,492)10,0552,5884,271
Income (loss) from continuing operations:(15,712)(32,913)(19,440)(12,407)3,324(5,910)(7,440)
Income from discontinued operations     1,484 
Net income (loss):(15,712)(32,913)(19,440)(12,407)3,324(4,426)(7,440)
Other undisclosed net income (loss) attributable to parent 6,4833,8742,492(10,055)(2,588)(4,271)
Net loss attributable to parent:(15,712)(26,431)(15,566)(9,914)(6,732)(7,013)(11,711)
Other undisclosed net loss available to common stockholders, basic   (1,412)   
Net loss available to common stockholders, diluted:(15,712)(26,431)(15,566)(11,326)(6,732)(7,013)(11,711)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):(15,712)(32,913)(19,440)(12,407)3,324(4,426)(7,440)
Comprehensive income (loss), net of tax, attributable to parent:(15,712)(32,913)(19,440)(12,407)3,324(4,426)(7,440)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: